Gland Pharma Ltd.NSE: GLAND

Press Release Aug 26 2025

· Issued by Gland Pharma Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-26-2025-4

Gland Pharma Limited has informed the Exchange regarding a press release dated August 26, 2025, titled "Gland Pharma receives approval from the United States Food and Drug Administration (USFDA) for Vasopressin 5% Dextrose Injection USP (RTU vial)".

View Attachment

6ix hasn’t read this filing yet.

Gland Pharma Ltd. on 6ix

Earlier from Gland Pharma

Later from Gland Pharma

All Gland Pharma news releases